Published in Cardiovascular Business Week, March 14th, 2006
Cardiovascular surgeons in the United States conducted a study "to evaluate the prophylactic effect of diltiazem on the incidence of atrial arrhythmia (fibrillation and/or flutter) following coronary artery bypass grafting (CABG)."
"Data were retrospectively gathered," noted N. Dobrilovic and coauthors working at the Jewish Hospital in Cincinnati. "Patients undergoing elective CABG by one surgeon at one institution over a 3-year period were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.